Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Services
  • Home
  • Construction
  • Business
  • Education
Washingtoner

Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
Washingtoner/10239600

Trending...
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Spokane: Water Wise Wednesday Workshops Begin March 4
A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

BOISE, Idaho - Washingtoner -- Lotus Vaping Technologies, LLC, a Boise, Idaho-based manufacturer of bottled e-liquids for use in electronic nicotine delivery systems ("ENDS") or e-cigarettes, announced today that a rigorous three-month longitudinal cohort study of several of its FreenomsTM branded flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

The three-month study conducted from March 2023 to August 2023 involved 451 randomly assigned participants who were cigarette smokers, 221 of which were assigned to a control group that used only tobacco-flavored e-liquid, and 230 of which were assigned to a group that could use any of five different non-tobacco flavored bottled e-liquids, including Lotus's proprietary BluenomenomTM, StranomenonTM, X2 Cactus Jackfruit, and White Peach Raspberry flavors.

More on Washingtoner
  • Independent Financial Agencies Upgrade City of Tacoma's Bond Ratings Amid Broader Economic Uncertainty
  • City of Spokane Partners with North Hill Christian Church, Jewels Helping Hands to Open New Scattered Site Shelter
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • Tacoma City Council Votes to Enter Negotiations with Hyun Kim for City Manager Role
  • Tacoma: Registration Now Open for Grit City Connect Networking Event

At the end of three months, the average number of cigarettes smoked per day ("CPD") by the tobacco-flavored control group was reduced from 12.51 to 9.54, for a 23.72% reduction, while for the flavored e-liquid group, the average CPD was reduced from 11.70 to 6.88, for a 41.25% reduction.  The reduction in cigarettes smoked per day was thus 73.9% greater for the flavored group than the tobacco-flavored group. The study results also demonstrated statistically significant differences between several of Lotus's flavored e-liquids when compared head-to-head against tobacco-flavored e-liquids with respect to CPD reduction.

Additionally, a full 14.3% of study participants in the flavored group had quit smoking cigarettes altogether by the end of the third month—a rate that is substantially higher than that typically reported for FDA-approved nicotine replacement therapy products (9.0%).

Lotus's Director of Sales, Mike Larsen stated, "We are very excited about these study results. This study demonstrates what users of our products have known anecdotally for a long time—flavored e-liquids are more effective than tobacco flavor at promoting cigarette smoking reduction and cessation. The FDA has been asking for this data—we hope it will now take it into consideration when reviewing our premarket tobacco product applications and grant our flavored products the marketing authorizations that they deserve."

More on Washingtoner
  • HiLine Homes Celebrates Grand Opening of Marysville Model Home with Ribbon-Cutting Ceremony
  • Spokane: City Council Bans Use of Private Property for Detention Facilities
  • Spring Surge in 55+ Communities: What Buyers and Sellers Need to Know in 2026
  • Spokane: City Council Adopts "Immigration Enforcement Free Zones" Ordinance
  • Spokane City Council Approves Prohibition of Kraton Sales

About Lotus Vaping Technologies, LLC – Creator of NomenonsTM E-Liquids

Established in 2013, Lotus is a leading manufacturer and wholesaler of premium e-liquids in the United States providing a diverse range of vapor products for sale to adult consumers that satisfy a wide variety of consumer preferences and serve as alternatives to combustible cigarettes. Lotus is committed to responsible manufacturing processes and utilizes only the highest standards in its e-liquid production.

Media Contact
Mike Larsen
mike@lotusecigs.com


Source: Lotus Vaping Technologies, LLC

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • FlintLab Announces AI Test Group as Nexus Pioneer Partner
  • P-Wave Classics to publish Robert Bage's Hermsprong in three volumes, beginning 12 May
  • City of Spokane Launches Residential Light Program
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Spokane: Funding Available for Tourism and Cultural Investment Grant
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • Our Purpose ​ —To give "We The People" their voice back—
  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • Spokane: SPD Releases the Names of the Officers Involved in the OIS on Carlisle
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Firefighters Contain Two Separate West Spokane Fires Thursday Afternoon
  • Tacoma: WIAA/Gesa Credit Union Basketball Tournament
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Primeindexer Google indexing platform launched by SEO Danmark APS
_catLbl0 _catLbl1

Popular on Washingtoner

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 131
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Male In Custody After North Spokane Drive By Shooting
  • City of Tacoma Offers In-Person Workshop for Local Businesses on the Revolving Loan Fund Process
  • Investigation Into North Spokane Shooting That Left Two Dead Continues
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • City Council Confirms Appointment of Patti Jackson as Tacoma’s Police Chief
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Nashville International Chopin Piano Competition Launches First Amateur Edition
  • Aries Industries Streamlines Sewer Inspection Process With Introduction of the LETS Sidewinder

Similar on Washingtoner

  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute